These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 33587978)

  • 1. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
    Lin Z; Xie X; Lu S; Liu T
    Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA.
    Chen H; Gong Z; Zhou H; Han Y
    Drug Dev Res; 2024 Apr; 85(2):e22167. PubMed ID: 38444106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance.
    Qin S; Wang Y; Ma C; Lv Q
    Eur J Med Res; 2023 Sep; 28(1):354. PubMed ID: 37717007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Wnt/β-catenin cascade in osteosarcoma: The potential of ncRNAs as biomarkers and therapeutics.
    Fuloria S; Yadav G; Menon SV; Ali H; Pant K; Kaur M; Deorari M; Sekar M; Narain K; Kumar S; Fuloria NK
    Pathol Res Pract; 2024 Jul; 259():155346. PubMed ID: 38781762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
    Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
    Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis.
    Wang Y; Zhang L; Zheng X; Zhong W; Tian X; Yin B; Tian K; Zhang W
    Cancer Lett; 2016 Nov; 382(2):137-146. PubMed ID: 27609068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
    Lin Z; Lu S; Xie X; Yi X; Huang H
    Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.
    Wang C; Jing J; Cheng L
    Invest New Drugs; 2018 Dec; 36(6):1116-1132. PubMed ID: 30079443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
    Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
    Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance.
    Zhu KP; Zhang CL; Ma XL; Hu JP; Cai T; Zhang L
    Mol Ther; 2019 Mar; 27(3):518-530. PubMed ID: 30692017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research progress on the role of lncRNA, circular RNA, and microRNA networks in regulating ferroptosis in osteosarcoma.
    Yan C; Dou Y; Xia R; Liu S; Fu J; Li D; Wang R; Tie F; Li L; Jin H; An F
    Biomed Pharmacother; 2024 Jul; 176():116924. PubMed ID: 38876052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-coding RNAs in Cisplatin Resistance in Osteosarcoma.
    Ferretti VA; León IE
    Curr Treat Options Oncol; 2021 Mar; 22(5):41. PubMed ID: 33745006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
    Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D
    Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
    Lin BC; Huang D; Yu CQ; Mou Y; Liu YH; Zhang DW; Shi FJ
    Med Sci Monit; 2016 May; 22():1761-5. PubMed ID: 27222034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.
    Wang M; Yu F; Chen X; Li P; Wang K
    Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the roles of circular RNAs in osteosarcoma.
    Li Z; Li X; Xu D; Chen X; Li S; Zhang L; Chan MTV; Wu WKK
    Cell Prolif; 2021 Jan; 54(1):e12936. PubMed ID: 33103338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
    Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
    Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma.
    Tang Z; Lu Y; Chen Y; Zhang J; Chen Z; Wang Q
    Technol Cancer Res Treat; 2021; 20():15330338211034262. PubMed ID: 34323141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis.
    Han Z; Shi L
    Biochem Biophys Res Commun; 2018 Jan; 495(1):947-953. PubMed ID: 29170124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy.
    Chen D; Liu D; Chen Z
    Tumour Biol; 2017 Sep; 39(9):1010428317705762. PubMed ID: 28933259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.